![Increase in the density of CD20 improves the efficacy of rituximab (... | Download Scientific Diagram Increase in the density of CD20 improves the efficacy of rituximab (... | Download Scientific Diagram](https://www.researchgate.net/profile/Yves-Renaudineau/publication/23259859/figure/fig2/AS:310568687816706@1451056753294/Increase-in-the-density-of-CD20-improves-the-efficacy-of-rituximab-RTX-A-left.png)
Increase in the density of CD20 improves the efficacy of rituximab (... | Download Scientific Diagram
![Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease | American Society of Nephrology Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/31/11/2688/F1.medium.gif)
Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease | American Society of Nephrology
![Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura - The Journal of Pediatrics Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura - The Journal of Pediatrics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/94c6329d-1482-4a08-8383-4ace3dbf0428/gr1_lrg.jpg)
Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura - The Journal of Pediatrics
![Rituximab-Monotherapie im Vergleich zur Kombination von RTX mit Methotrexat oder Leflunomid – eine deutsche Studie zur Therapie der aktiven RA mit RTX in der täglichen Routine – rheuma-online Rituximab-Monotherapie im Vergleich zur Kombination von RTX mit Methotrexat oder Leflunomid – eine deutsche Studie zur Therapie der aktiven RA mit RTX in der täglichen Routine – rheuma-online](https://www.rheuma-online.de/uploads/pics/RTX-Kombi.jpg)
Rituximab-Monotherapie im Vergleich zur Kombination von RTX mit Methotrexat oder Leflunomid – eine deutsche Studie zur Therapie der aktiven RA mit RTX in der täglichen Routine – rheuma-online
![Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig3_HTML.png)
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
![A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2004293341/2017814654/gr3.jpg)
A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
![Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2014/10/Paper-28178-abstract-27709-0.jpg)
Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts
![Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX) treatment history as well as relapse history for 100 days prior to the first RTX. - ppt download Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX) treatment history as well as relapse history for 100 days prior to the first RTX. - ppt download](https://slideplayer.com/16987602/98/images/slide_1.jpg)
Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX) treatment history as well as relapse history for 100 days prior to the first RTX. - ppt download
![Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... | Download Scientific Diagram Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... | Download Scientific Diagram](https://www.researchgate.net/profile/Rosa-Molfetta-2/publication/280582156/figure/fig4/AS:280886995111937@1443980086030/Rituximab-RTX-stimulation-induces-SHP-1-recruitment-to-CD16-z-chain-SHP-1-inhibition.png)
Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... | Download Scientific Diagram
![Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology](https://kidney360.asnjournals.org/content/kidney360/1/5/359/F1.large.jpg)
Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology
![Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram](https://www.researchgate.net/profile/Yves-Renaudineau/publication/326842632/figure/fig4/AS:656719470395392@1533585531602/Hypersialylation-characterizes-CLL-cells-resistant-to-rituximab-RTX-induced.png)
Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram
![Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram](https://www.researchgate.net/profile/Michael-Centola/publication/8471126/figure/fig1/AS:267721455697958@1440841177264/Percentage-of-apoptosis-in-untreated-versus-rituximab-RTX-treated-peripheral-blood-B.png)
Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram
![In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram](https://www.researchgate.net/publication/349166570/figure/fig4/AS:995501566590977@1614357477657/In-vitro-and-in-vivo-treatment-with-rituximab-RTX-leads-to-CD20KO-phenotype-A-Flow.png)
In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram
![Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12948-019-0113-3/MediaObjects/12948_2019_113_Fig1_HTML.png)
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
![Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis - ScienceDirect Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165572819300645-ga1.jpg)
Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis - ScienceDirect
![Rituximab (RTX) treatment correlates with significant attenuation of... | Download Scientific Diagram Rituximab (RTX) treatment correlates with significant attenuation of... | Download Scientific Diagram](https://www.researchgate.net/publication/303467017/figure/fig4/AS:373644472668162@1466095192125/Rituximab-RTX-treatment-correlates-with-significant-attenuation-of-transforming-growth.png)
Rituximab (RTX) treatment correlates with significant attenuation of... | Download Scientific Diagram
![Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis - The Journal of Allergy and Clinical Immunology: In Practice Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis - The Journal of Allergy and Clinical Immunology: In Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/eab6356c-31b3-4dd8-b7c3-0fc409c0fa3f/gr1.jpg)
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis - The Journal of Allergy and Clinical Immunology: In Practice
![Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome | The Journal of Rheumatology Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/47/6/896/F2.large.jpg)
Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome | The Journal of Rheumatology
![Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity - Multiple Sclerosis and Related Disorders Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity - Multiple Sclerosis and Related Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f2378a97-ba81-498b-8f1d-a57d4f2df359/gr1.jpg)